What is Pineapple, Inc. (PNPL)?

Pineapple, Inc. (PNPL) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

What is the current price of PNPL?

The current price of PNPL is $0.00. Prices are updated in real time on Stocks360.

What is PNPL's price-to-earnings (PE) ratio?

PNPL's trailing twelve-month PE ratio is -10.43, based on current price and earnings per share data available on Stocks360.

What is PNPL's market capitalization?

PNPL's market capitalization is $36,552.00, placing it in the small-cap tier.

Pineapple, Inc. (PNPL)

Stock analysis · OTC · Healthcare · Medical - Pharmaceuticals

$0.00

Market Cap

$36.55K

PE (TTM)

-10.43

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.64

Day Range

$0.00 – $0.03

52-wk Range

$0.00 – $0.13

Avg Volume

N/A

Volume

20.00K

Pineapple, Inc. (PNPL) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $36.55K. Trailing PE -10.43. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $0.12 2026-10-29 · $0.00 (-99.57%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Pineapple, Inc.

Serving the cannabis industry, Pineapple, Inc. functions as a portfolio management firm. Its extensive asset portfolio encompasses a range of offerings, including operational guidance, technological support, intellectual property rights, and real estate rentals tailored for cannabis enterprises. The company also maintains equity investments in both retail and manufacturing segments of the cannabis market. Beyond these, Pineapple extends financing to its cannabis-focused clients, manages property leases for them, and delivers consulting services and technological expertise to facilitate the growth, enhancement, or establishment of new and existing business structures. Established in 1983, the firm's main offices are located in Los Angeles, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-10.43×
P/S (TTM)	9.20×
P/B	-0.01×
P/FCF (TTM)	0.00×
EV / EBITDA	-3700.91×
EV / Sales	2026.47×
Earnings Yield	-9.59%
Free Cash Flow Yield	0.00%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$8.05M
Revenue (TTM)	$3.97K
Net Income (TTM)	-$3.51K
Free Cash Flow (TTM)	$0.00
Net Debt	$8.02M
Working Capital	-$4.64M
Gross Margin	-50.98%
Operating Margin	-54.76%
Net Margin	-88.22%
Return on Equity	0.11%
Return on Invested Capital	-0.04%